Chardes
Thierry Chardes, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20140112931 | ANTI-HUMAN HER3 ANTIBODIES AND USES THEREOF - The present invention provides for isolated anti-human-HER3 antibodies or fragments thereof. More particularly the present invention provides an isolated monoclonal antibody that specifically binds to the extracellular domain of HER-3 and competes for binding to the extracellular domain of human HER-3 with the antibody produced obtainable from hybridoma deposited as CNCM-I-4486. The antibodies described in the present invention are useful for the treatment of cancer. | 04-24-2014 |
Thierry Chardes, Assas FR
Patent application number | Description | Published |
---|---|---|
20140141019 | ANTIBODIES AGAINST HER3 - The invention relates to antibodies against HER3 and their use in the treatment of cancer. | 05-22-2014 |
Thierry Chardes, Montpellier Cedex 5 FR
Patent application number | Description | Published |
---|---|---|
20140302041 | ANTI-AXL ANTIBODIES AND USES THEREOF - The present invention relates to anti-Axl antibodies and uses thereof in diagnostic and therapeutic methods. More particularly, the present invention relates to a monoclonal antibody having specificity for Axl comprising an heavy chain variable region comprising SEQ ID NO:2 in the H-CDR1 region, SEQ ID NO:3 in the H-CDR2 region and SEQ ID NO:4 in the H-CDR3 region; and a light chain variable region comprising SEQ ID NO: 6 in the L-CDR1 region, SEQ ID NO:7 in the L-CDR2 region and SEQ ID NO:8 in the L-CDR3 region. Said monoclonal antibody binds to the extracellular domain of Axl via, SEQ ID NO:9, SEQ ID NO: 10 and SEQ ID NO: 11. | 10-09-2014 |